Zithromax Powder, For Suspension
Product Images NDC 0069-3130

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Zithromax (NDC 0069-3130). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Zithromax 01)

Chemical structure diagram of the active ingredient in Zithromax, showing a complex molecular formula with multiple rings, oxygen, nitrogen atoms, and methyl groups.*

FDA Label Image

Logo (Zithromax 02)

FDA Label Image

Zithromax 02a

FDA Label Image

Principal Display Panel (250 mg)

Zithromax 250 mg tablets label by Pfizer Laboratories Div Pfizer Inc, NDC 0069-3060-30. The label states the active ingredient azithromycin, dosage form as tablets, container instructions, storage temperature (15° to 30°C), package count of 30 tablets, and includes dispensing and dosage information. The label includes lot and expiration fields and a barcode.*

FDA Label Image

Principal Display Panel (250 mg)

Zithromax (azithromycin) 250 mg tablets packaging label from Pfizer Laboratories Div Pfizer Inc. The label features a green background with the Zithromax logo and states a full course of antibiotic therapy in 5 daily doses. It includes dosing instructions using tablet illustrations showing the first day's dose and subsequent days. The package contains 6 tablets for prescription use only.*

FDA Label Image

Principal Display Panel (250 mg)

Packaging label for Zithromax (azithromycin) tablets, 250 mg strength. The label displays the product name, active ingredient, dosage strength, and notes distribution by Pfizer Labs, a division of Pfizer Inc., NY. It includes manufacturing details, lot and expiration area, and regulatory markings. Multiple identical labels are shown in a sheet layout.*

FDA Label Image

Principal Display Panel (250 mg)

Packaging label for Zithromax (azithromycin) Z-PAK by Pfizer Laboratories Div Pfizer Inc. The label features Zithromax branding and highlights that it contains 3 cards with 6 tablets, representing a full course of antibiotic therapy in 5 daily doses. The label uses a green background with white and yellow text, including barcodes and storage instructions.*

FDA Label Image

Principal Display Panel (250 mg Tablet Blister Pack Box)

Packaging label for Zithromax 250 mg tablets containing azithromycin, distributed by Pfizer Laboratories Division of Pfizer Inc. The label indicates 50 tablets per unit dose package, with directions for in-institution use only and storage instructions. The label includes dosage use information stating each tablet contains azithromycin dihydrate equivalent to 250 mg azithromycin.*

FDA Label Image

Principal Display Panel (500 mg)

Zithromax 500 mg tablets packaging label by Pfizer Laboratories Div Pfizer Inc. The label includes the brand name, active ingredient azithromycin, strength 500 mg, quantity of 30 tablets, and storage instructions. It also notes prescription use only and that the product is made in Singapore.*

FDA Label Image

Principal Display Panel (500 mg)

Zithromax (azithromycin) 500 mg Tablets TRI-PAK carton by Pfizer Laboratories Div Pfizer Inc. The package contains 3 tablets of 500 mg each with instructions indicating a full course of antibiotic therapy in 3 daily doses. The label includes dosing guidance, side effects information, and patient usage instructions with graphical tablet images for days 1 to 10.*

FDA Label Image

Principal Display Panel (500 mg)

Packaging label for Zithromax Tri-Pak 500 mg tablets by Pfizer Laboratories. The label indicates each tablet contains 500 mg azithromycin and the package includes 3 cards each with three tablets. The label features the Zithromax logo, NDC 0069-3070-75, storage instructions, and prescription-only designation.*

FDA Label Image

Principal Display Panel (500 mg)

Zithromax 500 mg tablet label distributed by Pfizer Labs, Division of Pfizer Inc., NY. Each label shows the proprietary name Zithromax, the active ingredient azithromycin, and the strength of 500 mg per tablet. Additional label details include a product code (PAA135273), barcode, and placeholders for expiration date and lot number information.*

FDA Label Image

Principal Display Panel (500 mg Tablet Blister Pack Box)

Packaging label for Zithromax 500 mg azithromycin tablets by Pfizer Laboratories Div Pfizer Inc. The label is for a unit dose package containing 50 tablets, marked for in-institution use only and prescription use (Rx only). It includes storage instructions, dosage direction references, and barcode information.*

FDA Label Image

Principal Display Panel (300 mg Bottle Label)

Zithromax 300 mg (azithromycin) oral suspension label, cherry flavored, containing 100 mg per 5 mL when mixed to 15 mL. The label includes instructions for mixing and storage, with a 10-day usage guideline after mixing. Manufactured by Pfizer Laboratories Div Pfizer Inc.*

FDA Label Image

Principal Display Panel (300 mg Bottle Carton)

Zithromax 300 mg (15 mL when mixed) oral suspension packaging label by Pfizer Laboratories Div Pfizer Inc. The active ingredient is azithromycin, with a concentration of 100 mg per 5 mL. The cherry-flavored suspension is for oral use only. The label includes storage instructions, dosage directions, and a barcode.*

FDA Label Image

Principal Display Panel (600 mg Bottle Label)

Zithromax (azithromycin) for oral suspension 200 mg per 5 mL, cherry flavored, in a 600 mg total powder bottle (15 mL when mixed) by Pfizer Laboratories Div Pfizer Inc. The label includes storage, mixing, and dosing instructions, a barcode, and NDC 0069-3120-19, with emphasis on shaking well before use and usage within 10 days after mixing.*

FDA Label Image

Principal Display Panel (600 mg Bottle Carton)

Packaging label for Zithromax (azithromycin) oral suspension 200 mg per 5 mL, 600 mg total when mixed in 15 mL. The label is cherry flavored and for oral use only. It includes storage instructions, dosage use note, and is distributed by Pfizer Labs, Division of Pfizer Inc. The label emphasizes shaking well before use, storing dry powder below 30°C, and additional handling instructions.*

FDA Label Image

Principal Display Panel (900 mg Bottle Label)

Label for Zithromax (azithromycin) oral suspension 200 mg per 5 mL, cherry flavored, in a 900 mg (22.5 mL when mixed) powder form for reconstitution. The label includes storage instructions, mixing directions, dosage usage note, and states the product is distributed by Pfizer Laboratories Div Pfizer Inc.*

FDA Label Image

Principal Display Panel (900 mg Bottle Carton)

Packaging label for Zithromax (azithromycin) oral suspension, 200 mg per 5 mL strength, in a 900 mg (22.5 mL when mixed) bottle. The label shows it is cherry flavored, for oral use only, and is distributed by Pfizer Laboratories, Division of Pfizer Inc. Storage and usage instructions are also included.*

FDA Label Image

Principal Display Panel (1200 mg Bottle Label)

Zithromax (azithromycin) oral suspension label showing 200 mg per 5 mL strength in a 1200 mg (30 mL when mixed) bottle. The label includes dosing and mixing instructions, storage conditions, and a cherry flavor indication. The product is labeled as Rx only and distributed by Pfizer Laboratories Div Pfizer Inc.*

FDA Label Image

Principal Display Panel (1200 mg Bottle Carton)

Label panel for Zithromax oral suspension, 200 mg per 5 mL (azithromycin), presented as a 1200 mg (30 mL when mixed) bottle. The label indicates the product is cherry flavored and for oral use only. It includes storage instructions, dosing notes, and the Pfizer logo with Pfizer Labs as the distributor.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.